as of end of April 2020Download
as of 30/04/2020
The market rebounded sharply in April, lifted by the economic response plans announced by governments and central banks, but also by investors’ perception that the peak of the epidemic is now over and that treatments, but also vaccines, are on the horizon. Sycomore Shared Growth outperformed thanks to the particularly strong returns posted by the health care industry. Ipsen rallied sharply as investors’ earlier pessimism seemed exaggerated in light of the most recent clinical and business statements. Sanofi reported a very strong first quarter and could feature among the pharmaceutical suffering a solution to the current health crisis, with Kevzara and several vaccine candidates. Finally, the epidemic has accelerated the shift toon-line drugs sales, a trend that has been favourable to Shop Apotheke and Zur Rose during the month.
You have tried to access the fund explorer which is specifically for the countries listed. Either select your country of location and investor type before proceeding, or return to your previous page by clicking back.
Please confirm your type of investor and country to proceed
Please select country
By continuing, you accept terms and conditions above.Accept and proceed